Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a link to the Genetic and Rare Diseases Information Center resources for squamous cell carcinoma of the head and neck, and a related topic entry for head and neck squamous cell carcinoma.
    Difference
    0.2%
    Check dated 2026-04-02T15:36:16.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:08:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3 in the header.
    Difference
    0.1%
    Check dated 2026-03-12T02:34:13.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and the v3.4.1 revision entry.
    Difference
    0.5%
    Check dated 2026-02-11T14:25:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and NIH Clinical Center operating status was added to the site; link to opm.gov for updates. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:39:44.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added and updated administrative metadata on the study page: No FEAR Act Data, Last Update Submitted that Met QC Criteria, Last Update Posted, and Revision: v3.4.0. Removed the older labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T06:34:58.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.